Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia

• Main Authors: Claassen Daniel O. MD (Author), Ayyagari Rajeev PhD (Author), García-Horton Viviana PhD (Author), Zhang Su PhD (Author), Leo Sam PharmD (Author)
• Formato: Livro
• Publicado em: American Association of Psychiatric Pharmacists, 2023-10-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Introduction Deutetrabenazine is approved for treatment of Huntington disease (HD)-related chorea and tardive dyskinesia (TD) in adults. Factors associated with deutetrabenazine persistence and adherence are not well understood. Methods Claims data from the Symphony Health Solutions Integrated Datav...